Frankfurt - Delayed Quote EUR

SCHOTT Pharma AG & Co. KGaA (1SXP.F)

22.70

+0.05

+(0.22%)

As of 8:12:55 AM GMT+2. Market Open.

SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

SCHOTT Pharma KGaA (ETR:1SXP) has had a rough three months with its share price down 5.4%. However, stock prices are...

Simply Wall St. 16 days ago

SHTPY
Analyst Estimates: Here's What Brokers Think Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) After Its First-Quarter Report

Last week saw the newest quarterly earnings release from SCHOTT Pharma AG & Co. KGaA ( ETR:1SXP ), an important...

Simply Wall St. last month

SHTPY
SCHOTT Pharma KGaA First Quarter 2025 Earnings: EPS Beats Expectations

SCHOTT Pharma KGaA ( ETR:1SXP ) First Quarter 2025 Results Key Financial Results Revenue: €229.8m (down 1.0% from 1Q...

Simply Wall St. last month

SHTPY
SCHOTT Pharma KGaA Full Year 2024 Earnings: EPS Beats Expectations

SCHOTT Pharma KGaA ( ETR:1SXP ) Full Year 2024 Results Key Financial Results Revenue: €957.1m (up 6.5% from FY 2023...

Simply Wall St. 3 months ago

SHTPY
A Look At The Fair Value Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

Key Insights The projected fair value for SCHOTT Pharma KGaA is €30.45 based on 2 Stage Free Cash Flow to Equity With...

Simply Wall St. 4 months ago

SHTPY
SCHOTT Pharma AG & Co. KGaA's (ETR:1SXP) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

With its stock down 11% over the past three months, it is easy to disregard SCHOTT Pharma KGaA (ETR:1SXP). However...

Simply Wall St. 5 months ago

SHTPY
Schott Pharma AG & CO KGaA (WBO:1SXP) Q3 2024 Earnings Call Highlights: Strong Revenue ...

Schott Pharma AG & CO KGaA (WBO:1SXP) reports a 21% revenue increase and raises its full-year growth guidance, while addressing challenges in production and currency impacts.

GuruFocus.com 6 months ago

SHTPY
Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry "Alliance for RTU"

PIOMBINO DESE, Italy, September 26, 2024--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, together with Gerresheimer AG (MDAX: GXI) and SCHOTT Pharma AG & Co. KGaA (MDAX: 1SXP), announced today that they have entered into a strategic industry alliance ("Alliance for RTU") to support market adoption of Ready-to-Use (RTU) vials and cartridges.

Business Wire 6 months ago

GRRMF

GRRMY

SHTPY
SCHOTT Pharma AG & Co. KGaA Just Beat EPS By 52%: Here's What Analysts Think Will Happen Next

As you might know, SCHOTT Pharma AG & Co. KGaA ( ETR:1SXP ) just kicked off its latest quarterly results with some very...

Simply Wall St. 7 months ago

SHTPY
SCHOTT Pharma KGaA Third Quarter 2024 Earnings: Beats Expectations

SCHOTT Pharma KGaA ( ETR:1SXP ) Third Quarter 2024 Results Key Financial Results Revenue: €253.6m (up 15% from 3Q...

Simply Wall St. 7 months ago

SHTPY
Is Weakness In SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

With its stock down 5.5% over the past month, it is easy to disregard SCHOTT Pharma KGaA (ETR:1SXP). But if you pay...

Simply Wall St. 11 months ago

1SXP.DE
+0.44%

Performance Overview

Return	1SXP.F	DAX P (^GDAXI)
YTD	-8.20%	+6.27%
1-Year	-39.53%	+19.09%
3-Year	-24.33%	+49.37%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

SCHOTT Pharma AG & Co. KGaA (1SXP.F)

SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Analyst Estimates: Here's What Brokers Think Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) After Its First-Quarter Report

SCHOTT Pharma KGaA First Quarter 2025 Earnings: EPS Beats Expectations

SCHOTT Pharma KGaA Full Year 2024 Earnings: EPS Beats Expectations

A Look At The Fair Value Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

SCHOTT Pharma AG & Co. KGaA's (ETR:1SXP) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Schott Pharma AG & CO KGaA (WBO:1SXP) Q3 2024 Earnings Call Highlights: Strong Revenue ...

Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry "Alliance for RTU"

SCHOTT Pharma AG & Co. KGaA Just Beat EPS By 52%: Here's What Analysts Think Will Happen Next

SCHOTT Pharma KGaA Third Quarter 2024 Earnings: Beats Expectations

Is Weakness In SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Performance Overview